IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/steadfast-group-ltd" target="_blank" data-smartkarma-citation="entities:8181:1" rel="noopener">Steadfast (SDF AU)</a> has entered a SID with Amwins, Dragoneer and KKR at A$6.00 per share, a 51.9% premium to the undisturbed price of A$3.95.</li>
<li>Since the disclosure of the non-binding proposal, the peers have materially re-rated, and the offer remains light compared to precedent transactions. </li>
<li>However, the scheme vote should pass, as the offer is reasonable relative to peer multiples and AusSuper, the largest shareholder, has not publicly opposed it.  </li>
</ul>



Steadfast (SDF AU) has entered a SID with Amwins, Dragoneer and KKR at A$6.00 per share, a 51.9% premium to the undisturbed price of A$3.95.
Since the disclosure of the non-binding proposal, the peers have materially re-rated, and the offer remains light compared to precedent transactions. 
However, the scheme vote should pass, as the offer is reasonable relative to peer multiples and AusSuper, the largest shareholder, has not publicly opposed it.  


Steadfast (SDF AU): Consortium’s Binding Proposal at A$6.00 as Peers Have Materially Re-Rated

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<ul>
<li>The S&amp;P 500 is 1% above the 4300-4325 area which we anticipated would cap upside for 2023.</li>
<li>Our view since our 5/30/23 ETF Pathfinder is that we cannot be bearish if the SPX is above 4050, and we subsequently moved that line-in-the-sand up to 4165-4200 on 6/6/23.</li>
<li>We are moving that threshold up to 4300, which is short-term support to watch; a break below it could bring selling pressure.</li>
</ul>


The S&amp;P 500 is 1% above the 4300-4325 area which we anticipated would cap upside for 2023.
Our view since our 5/30/23 ETF Pathfinder is that we cannot be bearish if the SPX is above 4050, and we subsequently moved that line-in-the-sand up to 4165-4200 on 6/6/23.
We are moving that threshold up to 4300, which is short-term support to watch; a break below it could bring selling pressure.


Consolidation Likely, But Little Reason to Be Bearish; Buys Within Biotech, Latin American Banks

<ul>
<li>
<a href="https://www.smartkarma.com/entities/steadfast-group-ltd" target="_blank" data-smartkarma-citation="entities:8181:1" rel="noopener">Steadfast (SDF AU)</a> disclosed a non-binding proposal from Amwins and Dragoneer at A$6.00 per share, a 51.9% premium to the undisturbed price of A$3.95.</li>
<li>While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with precedent transactions. </li>
<li>Regulatory approvals are low-risk, and the shareholder structure reduces the scheme voting risk. However, the NBIO could trigger a competing offer. </li>
</ul>



Steadfast (SDF AU) disclosed a non-binding proposal from Amwins and Dragoneer at A$6.00 per share, a 51.9% premium to the undisturbed price of A$3.95.
While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with precedent transactions. 
Regulatory approvals are low-risk, and the shareholder structure reduces the scheme voting risk. However, the NBIO could trigger a competing offer. 


Steadfast (SDF AU): Amwins and Dragoneer’s NBIO at A$6.00

<ul>
<li>In response to an AFR article, <a href="https://www.smartkarma.com/entities/aub-group-limited" target="_blank" data-smartkarma-citation="entities:11179:1" rel="noopener">AUB Group Limited (AUB AU)</a> confirmed that on 26 September, it received a non-binding proposal from <a href="https://www.smartkarma.com/entities/eqt-ab" target="_blank" data-smartkarma-citation="entities:28922:1" rel="noopener">EQT (EQT SS)</a> at A$45.00.</li>
<li>While the offer represents an all-time high, it is arguably light compared to precedent transactions and peer multiples. EQT's history of unsuccessful ASX tilts warrants some caution. </li>
<li>The Board has granted a six-week exclusive due diligence period, which ends on 20 November. The shareholder structure reduces the vote risk. </li>
</ul>


In response to an AFR article, AUB Group Limited (AUB AU) confirmed that on 26 September, it received a non-binding proposal from EQT (EQT SS) at A$45.00.
While the offer represents an all-time high, it is arguably light compared to precedent transactions and peer multiples. EQT's history of unsuccessful ASX tilts warrants some caution. 
The Board has granted a six-week exclusive due diligence period, which ends on 20 November. The shareholder structure reduces the vote risk. 


AUB Group (AUB AU): EQT’s NBIO at A$45.00

External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

Key points (machine generated)<ul><li>Brown &amp; Brown (BRO) is now the 4th largest insurance broker in the U.S. after acquiring Accession Risk Partners.</li><li>BRO's business model involves earning fixed commissions on insurance premiums, with expected organic growth of 4-6% through economic cycles.</li><li>The $9.4 billion acquisition, funded partly by a $4 billion equity raise, presents integration risks but offers potential synergies and is priced attractively at 12x EBITDA.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)Brown &amp; Brown (BRO) is now the 4th largest insurance broker in the U.S. after acquiring Accession Risk Partners.BRO's business model involves earning fixed commissions on insurance premiums, with expected organic growth of 4-6% through economic cycles.The $9.4 billion acquisition, funded partly by a $4 billion equity raise, presents integration risks but offers potential synergies and is priced attractively at 12x EBITDA.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Brown & Brown Inc (BRO) - Thursday, Jul 10, 2025

United States

Brown & Brown, Inc. and its subsidiaries provide a range of insurance and reinsurance products and services.  The Company also provides risk management, employee benefit administration, and managed health care services.  Brown & Brown operates offices across the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Brown & Brown (BRO US)

Steadfast (SDF AU): Consortium’s Binding Proposal at A$6.00 as Peers Have Materially Re-Rated

Despite the material re-rating of peers, the scheme vote should pass. At the last close and for an end-of-December payment, the gross/annualised...

Arun George

Consolidation Likely, But Little Reason to Be Bearish; Buys Within Biotech, Latin American Banks

$SPX is 1% above 4300-4325 which we anticipated would cap upside for 2023. Our view since May 30 (ETF Pathfinder) is we cannot be bearish if SPX is...

Vermilion Research

Steadfast (SDF AU): Amwins and Dragoneer’s NBIO at A$6.00

While the offer is attractive relative to peer multiples, it is arguably opportunistic, as it is below the 52-week high and light compared with...

Arun George

AUB Group (AUB AU): EQT’s NBIO at A$45.00

While the offer represents an all-time high, it is arguably light compared to precedent transactions and peer multiples.

Arun George

Brown & Brown Inc (BRO) - Thursday, Jul 10, 2025

Brown & Brown's recent $9.4 billion acquisition of Accession Risk Partners enhances its market position as the 4th largest U.S. broker, offering...

Value Investors Club (VIC)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)